Buy Stocks Easy | About Us
April 15, 2021
Buy Stocks Easy | Online Stocks

BCLI


Buy Brainstorm Cell Therapeutics Inc. Stock (symbol: BCLI) Easy Online

Company Name: Brainstorm Cell Therapeutics Inc.

Symbol: BCLI

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

IPO: 2003

BCLI Current Share Price

Today's BCLI ( Brainstorm Cell Therapeutics Inc. ) opening price: $3.7200

Yesterday's BCLI ( Brainstorm Cell Therapeutics Inc. ) closing price: $3.6900

Brainstorm Cell Therapeutics Inc. Stock ( symbol: BCLI ) Price Chart since IPO (2003):

12 Months Brainstorm Cell Therapeutics Inc. Stock ( symbol: BCLI ) Price Chart

Popular Questions about Brainstorm Cell Therapeutics Inc. Public Stock ( BCLI )

A: Brainstorm Cell Therapeutics Inc. stock symbol (also called stock or share ticker) is BCLI

A: Brainstorm Cell Therapeutics Inc. IPO (Initial Public Offering) took place on 2003

A: Brainstorm Cell Therapeutics Inc.'s stock (BCLI symbol) price at ther IPO (initial Public Offering) was $3.7200

Q: Is BCLI stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Brainstorm Cell Therapeutics Inc. stock (symbol: BCLI) at the beginning of 2019, at the opening share price of $3.6700, with a minimum of $200, by now your shares would be worth $11098 and your profit would be $10898 - SHOW ONLY IF PROFIT.

Buy Brainstorm Cell Therapeutics Inc. Stock Easy Online

Brainstorm Cell Therapeutics Inc. Stock Ticker Price Chart since IPO:





Brainstorm Cell Therapeutics Inc. Stock Price Yesterday



 


Brainstorm Cell Therapeutics Inc. Stock Price – Last Week




 


Brainstorm Cell Therapeutics Inc. Stock Price – Last Month




 


Brainstorm Cell Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962634/0/en/NurOwn-Data-Safety-Monitoring-Board-Recommends-MS-Phase-2-Clinical-Trial-Continue.html
                            

                                
NurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial Continue

                                
                                
NEW YORK, Dec.  19, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962038/0/en/BrainStorm-Issues-2019-Letter-to-Shareholders.html
                            

                                
BrainStorm Issues 2019 Letter to Shareholders

                                
                                
NEW YORK, Dec.  18, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959067/0/en/BrainStorm-Selected-as-Buzz-of-BIO-2020-Winner.html
                            

                                
BrainStorm Selected as Buzz of BIO 2020 Winner

                                
                                
NEW YORK, Dec.  11, 2019  (GLOBE NEWSWIRE) --  BrainStorm Cell Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1951816/0/en/BrainStorm-Announces-the-Mount-Sinai-Medical-Center-as-a-Progressive-MS-Phase-2-Clinical-Trial-Site.html
                            

                                
BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site

                                
                                
NEW YORK, Nov.  25, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/20/1950007/0/en/BrainStorm-Cell-Therapeutics-Announces-Publication-of-NurOwn-ALS-Phase-2-Randomized-Clinical-Trial-Data-in-Neurology.html
                            

                                
BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology

                                
                                
NEW YORK, Nov.  20, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/14/1947072/0/en/BrainStorm-Cell-Therapeutics-Announces-Research-Grant-Award-From-the-National-Multiple-Sclerosis-Society.html
                            

                                
BrainStorm Cell Therapeutics Announces Research Grant Award From the National Multiple Sclerosis Society

                                
                                
NEW YORK, Nov.  14, 2019  (GLOBE NEWSWIRE) --  BrainStorm Cell Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/12/1945051/0/en/BrainStorm-Cell-Therapeutics-Announces-Ralph-Kern-MD-MHSc-to-Present-at-the-7th-International-Stem-Cell-Meeting.html
                            

                                
BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem Cell Meeting

                                
                                
NEW YORK, Nov.  12, 2019  (GLOBE NEWSWIRE) --  BrainStorm Cell Ther...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4301794-interview-chaim-lebovits-ceo-brainstorm-cell-therapeutics
                            

                                
Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics

                                
                                
Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962634/0/en/NurOwn-Data-Safety-Monitoring-Board-Recommends-MS-Phase-2-Clinical-Trial-Continue.html
                            

                                
NurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial Continue

                                
                                
NEW YORK, Dec.  19, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962038/0/en/BrainStorm-Issues-2019-Letter-to-Shareholders.html
                            

                                
BrainStorm Issues 2019 Letter to Shareholders

                                
                                
NEW YORK, Dec.  18, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959067/0/en/BrainStorm-Selected-as-Buzz-of-BIO-2020-Winner.html
                            

                                
BrainStorm Selected as Buzz of BIO 2020 Winner

                                
                                
NEW YORK, Dec.  11, 2019  (GLOBE NEWSWIRE) --  BrainStorm Cell Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1951816/0/en/BrainStorm-Announces-the-Mount-Sinai-Medical-Center-as-a-Progressive-MS-Phase-2-Clinical-Trial-Site.html
                            

                                
BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site

                                
                                
NEW YORK, Nov.  25, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/20/1950007/0/en/BrainStorm-Cell-Therapeutics-Announces-Publication-of-NurOwn-ALS-Phase-2-Randomized-Clinical-Trial-Data-in-Neurology.html
                            

                                
BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology

                                
                                
NEW YORK, Nov.  20, 2019  (GLOBE NEWSWIRE) -- BrainStorm Cell Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/14/1947072/0/en/BrainStorm-Cell-Therapeutics-Announces-Research-Grant-Award-From-the-National-Multiple-Sclerosis-Society.html
                            

                                
BrainStorm Cell Therapeutics Announces Research Grant Award From the National Multiple Sclerosis Society

                                
                                
NEW YORK, Nov.  14, 2019  (GLOBE NEWSWIRE) --  BrainStorm Cell Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/12/1945051/0/en/BrainStorm-Cell-Therapeutics-Announces-Ralph-Kern-MD-MHSc-to-Present-at-the-7th-International-Stem-Cell-Meeting.html
                            

                                
BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem Cell Meeting

                                
                                
NEW YORK, Nov.  12, 2019  (GLOBE NEWSWIRE) --  BrainStorm Cell Ther...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4301794-interview-chaim-lebovits-ceo-brainstorm-cell-therapeutics
                            

                                
Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics

                                
                                
Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.